lobbying_activities: 2861518

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2861518	059eb52b-fb9a-442c-a2e9-1f85eb811139	Q3	RED+BLUE STRATEGIES	400693064	PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)	2022	third_quarter	MMM	PL 117-169 - The Inflation Reduction Act - Support for policies delaying the Trump-era Rebate Rule. S. 3700 - The INSULIN Act - Issues related to making insulin affordable for all Americans. Regulations focused on quality measures used in contracting relationships between pharmacy benefit managers and pharmacies (known as DIR). PL 117-2 - The American Rescue Plan Act - Implementation of policies related to increasing access to health care coverage, including access to prescription drugs, for Americans with both public and private insurance.	HOUSE OF REPRESENTATIVES,SENATE	70000		0	0	2022-10-08T09:40:46-04:00